Researchers Develop Potent CDK9 Inhibitor to Overcome Drug Resistance in Hematological Malignancies (IMAGE)
Caption
Novel compound IHMT-CDK9-24: Discovery and its potent antitumor activity in vitro and in vivo.
Credit
SHI Chenliang
Usage Restrictions
no
License
Original content